<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schmidt M</submitter><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Universitätsklinikum RWTH Aachen</funding><funding>Medizinische Fakultät, RWTH Aachen University</funding><funding>Else Kröner-Fresenius-Stiftung</funding><pagination>164</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11580436</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs) are essential components of the tumor microenvironment and play a critical role in cancer progression. Numerous studies have identified significant molecular differences between CAFs and normal tissue-associated fibroblasts (NAFs). In this study, we isolated CAFs and NAFs from liver tumors and conducted a comprehensive analysis of their DNA methylation profiles, integrating our finding with data from studies on other cancer types.&lt;h4>Results&lt;/h4>Our analysis revealed that several CAF samples exhibited aberrant DNA methylation patterns, which corresponded with altered gene expression levels. Notably, DNA methylation at liver CAF-specific CpG sites was linked to survival outcomes in liver cancer datasets. An integrative analysis using p</pubmed_abstract><journal>Clinical epigenetics</journal><pubmed_title>Cancer-associated fibroblasts reveal aberrant DNA methylation across different types of cancer.</pubmed_title><pmcid>PMC11580436</pmcid><funding_grant_id>FibroMap Corsortia</funding_grant_id><funding_grant_id>ForTra gGmbH PrickMe</funding_grant_id><funding_grant_id>SFB 1506/1</funding_grant_id><funding_grant_id>IZKF O3-3</funding_grant_id><funding_grant_id>WA 1706/12-2</funding_grant_id><funding_grant_id>WA1706/14-1</funding_grant_id><funding_grant_id>GE 2811/4-1 within CRU344/417911533</funding_grant_id><funding_grant_id>WA1706/11-1</funding_grant_id><funding_grant_id>363055819/GRK2415</funding_grant_id><pubmed_authors>Schmidt M</pubmed_authors><pubmed_authors>Costa IG</pubmed_authors><pubmed_authors>Cramer T</pubmed_authors><pubmed_authors>Wagner W</pubmed_authors><pubmed_authors>Maie T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cancer-associated fibroblasts reveal aberrant DNA methylation across different types of cancer.</name><description>&lt;h4>Background&lt;/h4>Cancer-associated fibroblasts (CAFs) are essential components of the tumor microenvironment and play a critical role in cancer progression. Numerous studies have identified significant molecular differences between CAFs and normal tissue-associated fibroblasts (NAFs). In this study, we isolated CAFs and NAFs from liver tumors and conducted a comprehensive analysis of their DNA methylation profiles, integrating our finding with data from studies on other cancer types.&lt;h4>Results&lt;/h4>Our analysis revealed that several CAF samples exhibited aberrant DNA methylation patterns, which corresponded with altered gene expression levels. Notably, DNA methylation at liver CAF-specific CpG sites was linked to survival outcomes in liver cancer datasets. An integrative analysis using p</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-04-04T01:21:29.508Z</modification><creation>2025-04-04T01:21:29.508Z</creation></dates><accession>S-EPMC11580436</accession><cross_references><pubmed>39567960</pubmed><doi>10.1186/s13148-024-01783-y</doi></cross_references></HashMap>